Royal Bank of Canada
BIOR

Royal Bank of Canada’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Royal Bank of Canada’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7
Closed – – 7766
2024
Q2 		$0 Sell
7
-1
-13% -$7 ﹤0.01% 7809
2024
Q1 		$0 Buy
+8
New +$87 ﹤0.01% 7890
2023
Q2 		– Sell
-2
Closed – – 8004
2023
Q1 		$0 Buy
+2
New +$68 ﹤0.01% 7852
2022
Q4 		– Sell
-1
Closed -$73 – 8076
2022
Q3 		$0 Hold
1
– – ﹤0.01% 8161
2022
Q2 		$0 Sell
1
-3
-75% -$632 ﹤0.01% 8071
2022
Q1 		$1K Sell
4
-4
-50% -$1.52K ﹤0.01% 7668
2021
Q4 		$4K Buy
8
+7
+700% +$5.02K ﹤0.01% 7307
2021
Q3 		$0 Sell
1
-3
-75% -$1.29K ﹤0.01% 8037
2021
Q2 		$4K Sell
4
-92
-96% -$70.4K ﹤0.01% 7154
2021
Q1 		$114K Buy
96
+94
+4,700% +$130K ﹤0.01% 5372
2020
Q4 		$3K Sell
2
-6
-75% -$8.8K ﹤0.01% 6830
2020
Q3 		$18K Buy
+8
New +$18.1K ﹤0.01% 5743

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada's BIOR Position: Q3 2024 in Review

Royal Bank of Canada sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2024, closing a stake of 7 shares.

Royal Bank of Canada first reported a position in BIOR in Q3 2020 and held it in 12 quarters. The position peaked at $114K in Q1 2021. 20 funds tracked by Wall St. Rank hold BIOR as of Q3 2024.

  • Royal Bank of Canada reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 7 Biora Therapeutics, Inc. Common Stock shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • Royal Bank of Canada's Biora Therapeutics, Inc. Common Stock position peaked at $114K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.